Evidence map›Paper›PMID 27581446›Full record

ArticleThe Journal of neuroscience : the official journal of the Society for Neuroscience2016

Pharmacologically Counteracting a Phenotypic Difference in Cerebellar GABAA Receptor Response to Alcohol Prevents Excessive Alcohol Consumption in a High Alcohol-Consuming Rodent Genotype.

Josh Steven Kaplan, Michelle A Nipper, Ben D Richardson, Jeremiah Jensen, Melinda Helms, Deborah Ann Finn, David James Rossi

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of neuroscience : the official journal of the Society for Neuroscience, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
0.7field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 16 citations in OpenAlex.

  1. Article
  2. Article
  3. Synaptic Effects Induced by Alcohol.Current topics in behavioral neurosciences · 2025
    Review
  4. Behavioral decline in Shank3Molecular autism · 2024
    Article
  5. Behavioral regression in shank3Research square · 2024
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. The Cerebellar GABAHandbook of experimental pharmacology · 2018
    Article
  13. Review
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Josh Steven KaplanOregon Health & Science University, Department of Behavioral Neuroscience, Portland, Oregon 97239, Veterans Administration Portland Health Care System, Portland, Oregon 97239, and.
Michelle A NipperOregon Health & Science University, Department of Behavioral Neuroscience, Portland, Oregon 97239, Veterans Administration Portland Health Care System, Portland, Oregon 97239, and.
Ben D RichardsonWashington State University, Integrative Physiology and Neuroscience, Pullman, Washington 99164.
Jeremiah JensenOregon Health & Science University, Department of Behavioral Neuroscience, Portland, Oregon 97239.
Melinda HelmsOregon Health & Science University, Department of Behavioral Neuroscience, Portland, Oregon 97239, Veterans Administration Portland Health Care System, Portland, Oregon 97239, and.
Deborah Ann FinnOregon Health & Science University, Department of Behavioral Neuroscience, Portland, Oregon 97239, Veterans Administration Portland Health Care System, Portland, Oregon 97239, and.
David James RossiOregon Health & Science University, Department of Behavioral Neuroscience, Portland, Oregon 97239, Washington State University, Integrative Physiology and Neuroscience, Pullman, Washington 99164 rossid@vetmed.wsu.edu.
Oregon Health & Science University · USWashington State University · US

Funding

BIOLOGICAL BASES OF ALCOHOLISMT32AA007468 · NIAAA · OREGON HEALTH & SCIENCE UNIVERSITY · PI Andrey E Ryabinin · 1987 to 2026
$11.3M
NEUROSTEROID MODULATION OF ETHANOL WITHDRAWAL SEVERITYR01AA012439 · NIAAA · OREGON HEALTH & SCIENCE UNIVERSITY · PI FINN, DEBORAH A., ROSSI, DAVID J · 2000 to 2017
$4.6M
Cerebellar GABAA receptor contributions to EtOH intoxication and EtOH intakeF31AA022267 · NIAAA · OREGON HEALTH & SCIENCE UNIVERSITY · PI KAPLAN, JOSHUA STEVEN · 2013 to 2014
$81k
NIAAA NIH HHS F31 AA022267NIAAA NIH HHS R01 AA012439NIAAA NIH HHS T32 AA007468
6 · The paper itself

Abstract

unlabelledCerebellar granule cell GABAA receptor responses to alcohol vary as a function of alcohol consumption phenotype, representing a potential neural mechanism for genetic predilection for alcohol abuse (Kaplan et al., 2013; Mohr et al., 2013). However, there are numerous molecular targets of alcohol in the cerebellum, and it is not known how they interact to affect cerebellar processing during consumption of socially relevant amounts of alcohol. Importantly, direct evidence for a causative role of the cerebellum in alcohol consumption phenotype is lacking. Here we determined that concentrations of alcohol that would be achieved in the blood after consumption of 1-2 standard units (9 mm) suppresses transmission through the cerebellar cortex in low, but not high, alcohol consuming rodent genotypes (DBA/2J and C57BL/6J mice, respectively). This genotype-selective suppression is mediated exclusively by enhancement of granule cell GABAA receptor currents, which only occurs in DBA/2J mice. Simulating the DBA/2J cellular phenotype in C57BL/6J mice by infusing the GABAA receptor agonist, 4,5,6,7-tetrahydroisoxazolo-[5,4-c]pyridine-3-ol hydrochloride, into cerebellar lobules IV-VI, in vivo, significantly reduced their alcohol consumption and blood alcohol concentrations achieved. 4,5,6,7-Tetrahydroisoxazolo-[5,4-c]pyridine-3-ol hydrochloride infusions also significantly decreased sucrose consumption, but they did not affect consumption of water or general locomotion. Thus, genetic differences in cerebellar response to alcohol contributes to alcohol consumption phenotype, and targeting the cerebellar GABAA receptor system may be a clinically viable therapeutic strategy for reducing excessive alcohol consumption. SIGNIFICANCE STATEMENT: Alcohol abuse is a leading cause of preventable death and illness; and although alcohol use disorders are 50%-60% genetically determined, the cellular and molecular mechanisms of such genetic influences are largely unknown. Here we demonstrate that genetic differences in cerebellar granule cell GABAA receptor responses to recreational concentrations of alcohol are the primary determinant of alcohol's impact on cerebellar processing and that pharmacologically modifying such responses alters alcohol consumption. These data highlight the cerebellum as an important neuroanatomical region in alcohol consumption phenotype and as a target for pharmacological treatment of alcohol use disorders. The results also add to the growing list of cognitive/emotional roles of the cerebellum in psychiatric disease and drug abuse.

Indexed as

Alcohol DrinkingCerebellumAnalysis of VarianceAnimalsAnimals, NewbornDose-Response Relationship, DrugEthanolExcitatory Amino Acid AntagonistsExcitatory Postsynaptic PotentialsGABA AgonistsGABA AntagonistsGenotypeIn Vitro TechniquesIsoxazolesKynurenic AcidLocomotionEthanolExcitatory Amino Acid AntagonistsGABA AgonistsGABA AntagonistsgabazinegaboxadolIsoxazolesKynurenic AcidPyridazinesReceptors, GABA-ASucroseaddictionalcoholcerebellumGABATHIP

Identifiers

PMID27581446
PMCPMC5005716
OpenAlexW2507785324

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.